6 breakthroughs in biopharma logistics for emerging economies in 2026
In early 2026, the focus of global biopharmaceutical infrastructure has shifted toward ensuring equitable access to advanced therapies in the Global South. Governments in South Asia and Latin America are launching new "biotech corridors" that pair local manufacturing capabilities with international cold-chain standards. This initiative is designed to reduce the shelf-price of life-saving...
0 Comentários 0 Compartilhamentos 100 Visualizações 0 Anterior
Lifesone https://lifesone.com